Core Insights - Datatrak International has secured a $6,600,000 contract for its eTMF, ePRO/eCOA, and eConsent solutions, aimed at enhancing clinical trial documentation and processes [2][3] - The Datatrak eClinical Technology Platform is highlighted as the only true eSource solution that integrates various clinical trial management functions into a single user-friendly dashboard [1][4] Company Update - The contract will enable the integration of Datatrak's eTMF, ePRO/eCOA, and eConsent with EDC, RTSM, and CTMS, driving efficiency and improving visibility across data management needs for clinical trials [2][3] - Datatrak's platform is designed to be flexible and customizable, allowing it to meet diverse protocol requirements while providing total control over data, documents, workflows, and permissions [3][4] Technology and Compliance - The eClinical system is compliant with high-quality assurance standards, including Part 11, HIPAA, and GDPR, which enhances overall operational efficiency [3][6] - Datatrak's technology aims to reduce costs associated with medical device and drug development by offering competitively priced solutions compared to other eClinical vendors [3][6] Market Position - Datatrak has over 30 years of experience in the life sciences industry, being a pioneer in EDC and cloud software, and is trusted in 83 countries with over 10,000 clinical trials conducted [6]

After seeing Datatrak eTMF, CRO decides to switch its eTMF from a well-known vendor to Datatrak for all its clinical trials across its global organization. Datatrak eTMF seamlessly integrates into eSource dashboards for permissions granted to EDC users to view and upload documents from eTMF and participate in eTMF workflows directly with EDC and eSource dashboards all with one login. ...